Extracellular Vesicle-Packaged miR-195-5p Sensitizes Melanoma to Targeted Therapy with Kinase Inhibitors

Management of advanced melanoma remains challenging, with most BRAF (B-Raf proto-oncogene, serine/threonine kinase)-mutated metastatic patients relapsing within a few months upon MAPK inhibitors treatment. Modulation of tumor-derived extracellular vesicle (EVs) cargo with enrichment of antitumoral m...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Nathalia L., Bustos, Silvina O., Reis, Patricia P., Chammas, Roger, Andrade, Luciana N. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177607/
https://www.ncbi.nlm.nih.gov/pubmed/37174717
http://dx.doi.org/10.3390/cells12091317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177607/
https://www.ncbi.nlm.nih.gov/pubmed/37174717
http://dx.doi.org/10.3390/cells12091317

Ejemplares similares